Global Vaccine for Influenza Market Research Report 2025(Status and Outlook)

March 2025 | 158 pages | ID: G0D0F5926634EN
Bosson Research

Abstracts

Report Overview

The market for the Influenza vaccine consists of products designed to prevent individuals from contracting the influenza virus. This vaccine works by stimulating the immune system to produce antibodies against the virus, providing immunity to the disease. The Influenza vaccine is typically administered annually, as the virus strains can vary each flu season. The market for Influenza vaccines is characterized by the constant need for research and development to match the circulating strains of the virus. This market is driven by factors such as the increasing awareness of the importance of vaccination in preventing the spread of influenza, especially among high-risk populations such as the elderly, young children, and individuals with underlying health conditions. Additionally, government initiatives promoting vaccination campaigns and the growing focus on public health measures contribute to the market growth for Influenza vaccines. In recent years, technological advancements in vaccine production and distribution have also played a significant role in expanding the market reach and accessibility of Influenza vaccines.

This report provides a deep insight into the global Vaccine for Influenza market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine for Influenza Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine for Influenza market in any manner.

Global Vaccine for Influenza Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Market Segmentation (by Type)

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Market Segmentation (by Application)

6 Months to 3 Years

> 3 Years

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Vaccine for Influenza Market
• Overview of the regional outlook of the Vaccine for Influenza Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine for Influenza Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Vaccine for Influenza
1.2 Key Market Segments
1.2.1 Vaccine for Influenza Segment by Type
1.2.2 Vaccine for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Vaccine for Influenza Market Overview
2.1 Global Market Overview
2.1.1 Global Vaccine for Influenza Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Vaccine for Influenza Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Vaccine for Influenza Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Vaccine for Influenza Product Life Cycle
3.3 Global Vaccine for Influenza Sales by Manufacturers (2020-2025)
3.4 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaccine for Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
3.8 Vaccine for Influenza Market Competitive Situation and Trends
3.8.1 Vaccine for Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaccine for Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Vaccine for Influenza Industry Chain Analysis
4.1 Vaccine for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Vaccine for Influenza Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaccine for Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Vaccine for Influenza Market
5.7 ESG Ratings of Leading Companies
6 Vaccine for Influenza Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
6.3 Global Vaccine for Influenza Market Size Market Share by Type (2020-2025)
6.4 Global Vaccine for Influenza Price by Type (2020-2025)
7 Vaccine for Influenza Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine for Influenza Market Sales by Application (2020-2025)
7.3 Global Vaccine for Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Vaccine for Influenza Sales Growth Rate by Application (2020-2025)
8 Vaccine for Influenza Market Sales by Region
8.1 Global Vaccine for Influenza Sales by Region
8.1.1 Global Vaccine for Influenza Sales by Region
8.1.2 Global Vaccine for Influenza Sales Market Share by Region
8.2 Global Vaccine for Influenza Market Size by Region
8.2.1 Global Vaccine for Influenza Market Size by Region
8.2.2 Global Vaccine for Influenza Market Size Market Share by Region
8.3 North America
8.3.1 North America Vaccine for Influenza Sales by Country
8.3.2 North America Vaccine for Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccine for Influenza Sales by Country
8.4.2 Europe Vaccine for Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccine for Influenza Sales by Region
8.5.2 Asia Pacific Vaccine for Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaccine for Influenza Sales by Country
8.6.2 South America Vaccine for Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaccine for Influenza Sales by Region
8.7.2 Middle East and Africa Vaccine for Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Vaccine for Influenza Market Production by Region
9.1 Global Production of Vaccine for Influenza by Region(2020-2025)
9.2 Global Vaccine for Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Vaccine for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaccine for Influenza Production
9.4.1 North America Vaccine for Influenza Production Growth Rate (2020-2025)
9.4.2 North America Vaccine for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaccine for Influenza Production
9.5.1 Europe Vaccine for Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Vaccine for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaccine for Influenza Production (2020-2025)
9.6.1 Japan Vaccine for Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Vaccine for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaccine for Influenza Production (2020-2025)
9.7.1 China Vaccine for Influenza Production Growth Rate (2020-2025)
9.7.2 China Vaccine for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Vaccine for Influenza Product Overview
10.1.3 Sanofi Vaccine for Influenza Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Vaccine for Influenza Product Overview
10.2.3 CSL Vaccine for Influenza Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Vaccine for Influenza Product Overview
10.3.3 GSK Vaccine for Influenza Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Vaccine for Influenza Product Overview
10.4.3 Viatris Vaccine for Influenza Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Vaccine for Influenza Product Overview
10.5.3 AstraZeneca Vaccine for Influenza Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Vaccine for Influenza Product Overview
10.6.3 Hualan Bio Vaccine for Influenza Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Basic Information
10.7.2 Changchun Institute of Biological Vaccine for Influenza Product Overview
10.7.3 Changchun Institute of Biological Vaccine for Influenza Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Basic Information
10.8.2 Sinovac Vaccine for Influenza Product Overview
10.8.3 Sinovac Vaccine for Influenza Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 BCHT
10.9.1 BCHT Basic Information
10.9.2 BCHT Vaccine for Influenza Product Overview
10.9.3 BCHT Vaccine for Influenza Product Market Performance
10.9.4 BCHT Business Overview
10.9.5 BCHT Recent Developments
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Basic Information
10.10.2 Jiangsu GDK Vaccine for Influenza Product Overview
10.10.3 Jiangsu GDK Vaccine for Influenza Product Market Performance
10.10.4 Jiangsu GDK Business Overview
10.10.5 Jiangsu GDK Recent Developments
10.11 KM Biologics
10.11.1 KM Biologics Basic Information
10.11.2 KM Biologics Vaccine for Influenza Product Overview
10.11.3 KM Biologics Vaccine for Influenza Product Market Performance
10.11.4 KM Biologics Business Overview
10.11.5 KM Biologics Recent Developments
11 Vaccine for Influenza Market Forecast by Region
11.1 Global Vaccine for Influenza Market Size Forecast
11.2 Global Vaccine for Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine for Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine for Influenza Market Size Forecast by Region
11.2.4 South America Vaccine for Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccine for Influenza by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Vaccine for Influenza Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2026-2033)
12.1.2 Global Vaccine for Influenza Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Vaccine for Influenza by Type (2026-2033)
12.2 Global Vaccine for Influenza Market Forecast by Application (2026-2033)
12.2.1 Global Vaccine for Influenza Sales (K MT) Forecast by Application
12.2.2 Global Vaccine for Influenza Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccine for Influenza Market Size Comparison by Region (M USD)
Table 5. Global Vaccine for Influenza Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Vaccine for Influenza Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Vaccine for Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Vaccine for Influenza Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2024)
Table 10. Global Market Vaccine for Influenza Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Vaccine for Influenza Manufacturing Sites and Area Served
Table 12. Manufacturers Vaccine for Influenza Product Type
Table 13. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Vaccine for Influenza Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Vaccine for Influenza Sales by Type (K MT)
Table 25. Global Vaccine for Influenza Market Size by Type (M USD)
Table 26. Global Vaccine for Influenza Sales (K MT) by Type (2020-2025)
Table 27. Global Vaccine for Influenza Sales Market Share by Type (2020-2025)
Table 28. Global Vaccine for Influenza Market Size (M USD) by Type (2020-2025)
Table 29. Global Vaccine for Influenza Market Size Share by Type (2020-2025)
Table 30. Global Vaccine for Influenza Price (USD/MT) by Type (2020-2025)
Table 31. Global Vaccine for Influenza Sales (K MT) by Application
Table 32. Global Vaccine for Influenza Market Size by Application
Table 33. Global Vaccine for Influenza Sales by Application (2020-2025) & (K MT)
Table 34. Global Vaccine for Influenza Sales Market Share by Application (2020-2025)
Table 35. Global Vaccine for Influenza Market Size by Application (2020-2025) & (M USD)
Table 36. Global Vaccine for Influenza Market Share by Application (2020-2025)
Table 37. Global Vaccine for Influenza Sales Growth Rate by Application (2020-2025)
Table 38. Global Vaccine for Influenza Sales by Region (2020-2025) & (K MT)
Table 39. Global Vaccine for Influenza Sales Market Share by Region (2020-2025)
Table 40. Global Vaccine for Influenza Market Size by Region (2020-2025) & (M USD)
Table 41. Global Vaccine for Influenza Market Size Market Share by Region (2020-2025)
Table 42. North America Vaccine for Influenza Sales by Country (2020-2025) & (K MT)
Table 43. North America Vaccine for Influenza Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Vaccine for Influenza Sales by Country (2020-2025) & (K MT)
Table 45. Europe Vaccine for Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Vaccine for Influenza Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Vaccine for Influenza Market Size by Region (2020-2025) & (M USD)
Table 48. South America Vaccine for Influenza Sales by Country (2020-2025) & (K MT)
Table 49. South America Vaccine for Influenza Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Vaccine for Influenza Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Vaccine for Influenza Market Size by Region (2020-2025) & (M USD)
Table 52. Global Vaccine for Influenza Production (K MT) by Region(2020-2025)
Table 53. Global Vaccine for Influenza Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Vaccine for Influenza Revenue Market Share by Region (2020-2025)
Table 55. Global Vaccine for Influenza Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Vaccine for Influenza Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Vaccine for Influenza Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Vaccine for Influenza Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Vaccine for Influenza Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Sanofi Basic Information
Table 61. Sanofi Vaccine for Influenza Product Overview
Table 62. Sanofi Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Sanofi Business Overview
Table 64. Sanofi SWOT Analysis
Table 65. Sanofi Recent Developments
Table 66. CSL Basic Information
Table 67. CSL Vaccine for Influenza Product Overview
Table 68. CSL Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. CSL Business Overview
Table 70. CSL SWOT Analysis
Table 71. CSL Recent Developments
Table 72. GSK Basic Information
Table 73. GSK Vaccine for Influenza Product Overview
Table 74. GSK Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. GSK Business Overview
Table 76. GSK SWOT Analysis
Table 77. GSK Recent Developments
Table 78. Viatris Basic Information
Table 79. Viatris Vaccine for Influenza Product Overview
Table 80. Viatris Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Viatris Business Overview
Table 82. Viatris Recent Developments
Table 83. AstraZeneca Basic Information
Table 84. AstraZeneca Vaccine for Influenza Product Overview
Table 85. AstraZeneca Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Recent Developments
Table 88. Hualan Bio Basic Information
Table 89. Hualan Bio Vaccine for Influenza Product Overview
Table 90. Hualan Bio Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Hualan Bio Business Overview
Table 92. Hualan Bio Recent Developments
Table 93. Changchun Institute of Biological Basic Information
Table 94. Changchun Institute of Biological Vaccine for Influenza Product Overview
Table 95. Changchun Institute of Biological Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Changchun Institute of Biological Business Overview
Table 97. Changchun Institute of Biological Recent Developments
Table 98. Sinovac Basic Information
Table 99. Sinovac Vaccine for Influenza Product Overview
Table 100. Sinovac Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Sinovac Business Overview
Table 102. Sinovac Recent Developments
Table 103. BCHT Basic Information
Table 104. BCHT Vaccine for Influenza Product Overview
Table 105. BCHT Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. BCHT Business Overview
Table 107. BCHT Recent Developments
Table 108. Jiangsu GDK Basic Information
Table 109. Jiangsu GDK Vaccine for Influenza Product Overview
Table 110. Jiangsu GDK Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Jiangsu GDK Business Overview
Table 112. Jiangsu GDK Recent Developments
Table 113. KM Biologics Basic Information
Table 114. KM Biologics Vaccine for Influenza Product Overview
Table 115. KM Biologics Vaccine for Influenza Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. KM Biologics Business Overview
Table 117. KM Biologics Recent Developments
Table 118. Global Vaccine for Influenza Sales Forecast by Region (2026-2033) & (K MT)
Table 119. Global Vaccine for Influenza Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Vaccine for Influenza Sales Forecast by Country (2026-2033) & (K MT)
Table 121. North America Vaccine for Influenza Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Vaccine for Influenza Sales Forecast by Country (2026-2033) & (K MT)
Table 123. Europe Vaccine for Influenza Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Vaccine for Influenza Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Asia Pacific Vaccine for Influenza Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Vaccine for Influenza Sales Forecast by Country (2026-2033) & (K MT)
Table 127. South America Vaccine for Influenza Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Vaccine for Influenza Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Vaccine for Influenza Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Vaccine for Influenza Sales Forecast by Type (2026-2033) & (K MT)
Table 131. Global Vaccine for Influenza Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Vaccine for Influenza Price Forecast by Type (2026-2033) & (USD/MT)
Table 133. Global Vaccine for Influenza Sales (K MT) Forecast by Application (2026-2033)
Table 134. Global Vaccine for Influenza Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Vaccine for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine for Influenza Market Size (M USD), 2024-2033
Figure 5. Global Vaccine for Influenza Market Size (M USD) (2020-2033)
Figure 6. Global Vaccine for Influenza Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine for Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaccine for Influenza Product Life Cycle
Figure 13. Vaccine for Influenza Sales Share by Manufacturers in 2024
Figure 14. Global Vaccine for Influenza Revenue Share by Manufacturers in 2024
Figure 15. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Vaccine for Influenza Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaccine for Influenza Revenue in 2024
Figure 18. Industry Chain Map of Vaccine for Influenza
Figure 19. Global Vaccine for Influenza Market PEST Analysis
Figure 20. Global Vaccine for Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaccine for Influenza Market Share by Type
Figure 27. Sales Market Share of Vaccine for Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Vaccine for Influenza by Type in 2024
Figure 29. Market Size Share of Vaccine for Influenza by Type (2020-2025)
Figure 30. Market Size Share of Vaccine for Influenza by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaccine for Influenza Market Share by Application
Figure 33. Global Vaccine for Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Vaccine for Influenza Sales Market Share by Application in 2024
Figure 35. Global Vaccine for Influenza Market Share by Application (2020-2025)
Figure 36. Global Vaccine for Influenza Market Share by Application in 2024
Figure 37. Global Vaccine for Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaccine for Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Vaccine for Influenza Market Size Market Share by Region (2020-2025)
Figure 40. North America Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaccine for Influenza Sales Market Share by Country in 2024
Figure 43. North America Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaccine for Influenza Market Size Market Share by Country in 2024
Figure 45. U.S. Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaccine for Influenza Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaccine for Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaccine for Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaccine for Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaccine for Influenza Sales Market Share by Country in 2024
Figure 53. Europe Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaccine for Influenza Market Size Market Share by Country in 2024
Figure 55. Germany Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaccine for Influenza Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaccine for Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaccine for Influenza Market Size Market Share by Region in 2024
Figure 68. China Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaccine for Influenza Sales and Growth Rate (K MT)
Figure 79. South America Vaccine for Influenza Sales Market Share by Country in 2024
Figure 80. South America Vaccine for Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Vaccine for Influenza Market Size Market Share by Country in 2024
Figure 82. Brazil Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaccine for Influenza Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaccine for Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaccine for Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaccine for Influenza Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaccine for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaccine for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaccine for Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Vaccine for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaccine for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaccine for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaccine for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaccine for Influenza Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Vaccine for Influenza Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Vaccine for Influenza Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Vaccine for Influenza Market Share Forecast by Type (2026-2033)
Figure 111. Global Vaccine for Influenza Sales Forecast by Application (2026-2033)
Figure 112. Global Vaccine for Influenza Market Share Forecast by Application (2026-2033)